These innovations of 2026 could have a particularly broad impact

Some innovations have potential beyond the bounds of a single industry. These honorees include a company that is combining AI and advanced genetic life science to better track disease pathology, and another developing models that could help avoid animal testing by simulating human organ functions. Algen BiotechnologiesFor blending genetics and AI to advance pathologyOne of the most promising health applications for AI is earlier identification of genes that can be targeted by therapies to reverse disease processes. Spun out of Nobel Laureate Jennifer Doudna’s lab, Algen is the creator of AlgenBrain. It uses CRISPR and AI to better understand disease biology and accelerate next-generation approaches. The system maps causal links between gene regulation and disease progression, going beyond data analysis to generate solutions. The company recently announced a $555 million partnership with AstraZeneca to develop AI-powered drug discovery, giving Algen access to the pharmaceutical giant’s immunology pipeline. EmulateFor developing human organ simulators that can supplant animal testingOrgan-on-a-Chip technology from Emulate uses microfluidic devices containing human cells to replicate…